2 recruiting, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow Aaron Cook: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluorescent Probe for Assessment of Renal Elimination Relmapirazin, Iohexol, Medibeacon tGFR monitor - Augmented Renal Clearance, Critical Illness | Phase 4 | Recruiting | Aaron Cook | 200 | 2026-09-01 | 2026-10-07 |
| Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage Telavancin Injection - Subarachnoid Hemorrhage, Aneurysmal | Phase 4 | Recruiting | Aaron Cook | 20 | 2024-07-02 | 2025-12-26 |
| Continuous vs. Intermittent Infusion Vancomycin Vancomycin Continuous Infusion, Vancomycin Intermittent Infusion - Vancomycin | Phase 4 | Completed | Aaron Cook | 37 | 2023-05-22 | 2025-12-15 |
Acute Kidney Injury (1) · Critical Illness (1) · Subarachnoid Hemorrhage (1)
Iohexol (1) · Vancomycin (1) · relmapirazin (1) · telavancin (1)
United States (3)
Aaron M Cook, PharmD (3) · Juan-Carlos Aycinena, MD (1)
R21AI176298 (1)